NCT05003258View on ClinicalTrials.gov

Functional and Anatomical Outcomes of Dexamethasone Intra-vitreal Implant in Patients with Resistant Macular Edema Secondary to Retinal Vein Occlusion After Intravitreal Anti-VEGF Injection

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 7, 2021

Primary Completion Date

April 30, 2023

Study Completion Date

October 30, 2024

Conditions

Macular EdemaRetinal Vein Occlusion

Interventions

DEVICE

Intravitreal injection of Dexamethasone implant

Trial Locations (1)

Unknown

Faculty of medicine, Asyut

All Listed Sponsors

lead

Assiut University

OTHER

NCT05003258 - Functional and Anatomical Outcomes of Dexamethasone Intra-vitreal Implant in Patients with Resistant Macular Edema Secondary to Retinal Vein Occlusion After Intravitreal Anti-VEGF Injection | Biotech Hunter | Biotech Hunter